Higher expression of SALL4-A isoform is correlated with worse outcomes and progression of the disease in subtype of testicular germ cell tumours

References

• Al-Mousa A, Shashaa MN, Alkarrash MS, Alkhamis M, Ghabreau L, Dandal M. 2020. Unusual case of classic testicular seminoma in a 90-year-old patient: a case report. J Med Case Rep. 14:182.
   PubMedGoogle Scholar
• Almstrup K, Lobo J, Mørup N, Belge G, Rajpert-De Meyts E, Looijenga LHJ, Dieckmann K-P. 2020. Application of mirnas in the diagnosis and monitoring of testicular germ cell tumours. Nat Rev Urol. 17(4):201–213. doi: 10.1038/s41585-020-0296-x
   PubMed Web of Science ®Google Scholar
• Álvarez C, Quiroz A, Benítez-Riquelme D, Riffo E, Castro AF, Pincheira R. 2021. Sall proteins; common and antagonistic roles in cancer. Cancers (Basel). 13(24):6292. doi: 10.3390/cancers13246292
   PubMed Web of Science ®Google Scholar
• Bahrami A, Ro JY, Ayala AG. 2007. An overview of testicular germ cell tumours. Arch Pathol Lab Med. 131(8):1267–1280. doi: 10.5858/2007-131-1267-AOOTGC
   PubMed Web of Science ®Google Scholar
• Cao D, Guo S, Allan RW, Molberg KH, Peng Y. 2009. Sall4 Is a novel sensitive and specific marker of ovarian primitive germ cell tumours and is particularly useful in distinguishing yolk sac tumour from clear cell carcinoma. Am J Surg Pathol. 33(6):894–904. doi: 10.1097/PAS.0b013e318198177d
   PubMed Web of Science ®Google Scholar
• Cao D, Humphrey PA, Allan RW. 2009. Sall4 is a novel sensitive and specific marker for metastatic germ cell tumours, with particular utility in detection of metastatic yolk sac tumours. Cancer. 115(12):2640–2651. doi: 10.1002/cncr.24308
   PubMed Web of Science ®Google Scholar
• Cao D, Li J, Guo CC, Allan RW, Humphrey PA. 2009. Sall4 is a novel diagnostic marker for testicular germ cell tumours. Am J Surg Pathol. 33(7):1065–1077. doi: 10.1097/PAS.0b013e3181a13eef
   PubMed Web of Science ®Google Scholar
• Forghanifard MM, Moghbeli M, Raeisossadati R, Tavassoli A, Mallak AJ, Boroumand-Noughabi S, Abbaszadegan MR. 2013. Role of Sall4 in the progression and metastasis of colorectal cancer. J Biomed Sci. 20(1):6. doi: 10.1186/1423-0127-20-6
   PubMedGoogle Scholar
• Gautam AK, Wang C, Zeng J, Wang J, Lu J, Wei J, Huang G, Mo B, Luo M, Mo B. 2015. Expression and clinical significance of Sall4 and Lgr5 in patients with lung cancer. Oncol Lett. 10(6):3629–3634. doi: 10.3892/ol.2015.3772
   PubMed Web of Science ®Google Scholar
• Ghods R, Ghahremani MH, Madjd Z, Asgari M, Abolhasani M, Tavasoli S, Mahmoudi AR, Darzi M, Pasalar P, Jeddi-Tehrani M, et al. 2014. High placenta-specific 1/low prostate-specific antigen expression pattern in high-grade prostate adenocarcinoma. Cancer Immunol Immunother. 63(12):1319–1327. doi: 10.1007/s00262-014-1594-z
   PubMed Web of Science ®Google Scholar
• Hanna NH, Einhorn LH. 2014. Testicular cancer–discoveries and updates. N Engl J Med. 371(21):2005–2016. doi: 10.1056/NEJMra1407550
   PubMed Web of Science ®Google Scholar
• Jourdan F, Sebbagh N, Comperat E, Mourra N, Flahault A, Olschwang S, Duval A, Hamelin R, Flejou JF. 2003. Tissue microarray technology: validation in colorectal carcinoma and analysis of P53, Hmlh1, and Hmsh2 immunohistochemical expression. Virchows Arch. 443(2):115–121. doi: 10.1007/s00428-003-0833-z
   PubMed Web of Science ®Google Scholar
• Kalantari E, Razmi M, Tajik F, Asadi-Lari M, Ghods R, Madjd Z. 2022. Oncogenic functions and clinical significances of Dclk1 isoforms in colorectal cancer: a systematic review and meta-analysis. Cancer Cell Int. 22(1):217. doi: 10.1186/s12935-022-02632-9
   PubMed Web of Science ®Google Scholar
• Kollmannsberger C, Kuzcyk M, Mayer F, Hartmann JT, Kanz L, Bokemeyer C. 1999. Late toxicity following curative treatment of testicular cancer. Semin Surg Oncol. 17:275–281.
   PubMed Web of Science ®Google Scholar
• Lakpour N, Ghods R, Sadeghi MR, Ranjbar MM, Abolhasani M, Kiani J, Saliminejad K, Balay-Goli L, Bayat AA, Souri F, et al. 2022. Production and characterization of a new specific monoclonal antibody against a-isoform of Sall4: a novel emerging testicular cancer marker. Andrologia. 54(11):e14608. doi: 10.1111/and.14608
   PubMed Web of Science ®Google Scholar
• Lakpour N, Saliminejad K, Ghods R, Reza Sadeghi M, Pilatz A, Khosravi F, Madjd Z. 2021. Potential biomarkers for testicular germ cell tumour: risk assessment, diagnostic, prognostic and monitoring of recurrence. Andrologia. 53(4):e13998. doi: 10.1111/and.13998
   PubMed Web of Science ®Google Scholar
• Langer R, Von Rahden BH, Nahrig J, Von Weyhern C, Reiter R, Feith M, Stein HJ, Siewert JR, Hofler H, Sarbia M. 2006. Prognostic significance of expression patterns of C-Erbb-2, P53, P16ink4a, P27kip1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study. J Clin Pathol. 59:631–634.
   PubMed Web of Science ®Google Scholar
• Leao R, Ahmad AE, Hamilton RJ. 2019. Testicular cancer biomarkers: a role for precision medicine in testicular cancer. Clin Genitourin Cancer. 17:e176–e83.
   PubMed Web of Science ®Google Scholar
• Liu A, Cheng L, Du J, Peng Y, Allan RW, Wei L, Li J, Cao D. 2010. Diagnostic utility of novel stem cell markers Sall4, Oct4, Nanog, Sox2, Utf1, and Tcl1 in primary mediastinal germ cell tumours. Am J Surg Pathol. 34(5):697–706. doi: 10.1097/PAS.0b013e3181db84aa
   PubMed Web of Science ®Google Scholar
• Liu J, Sauer MA, Hussein SG, Yang J, Tenen DG, Chai L. 2021. Sall4 and microrna: the role of Let-7. Genes (Basel). 12(9):1301. doi: 10.3390/genes12091301
   PubMed Web of Science ®Google Scholar
• Liu C, Yao F, Mao X, Li W, Chen H. 2020. Effect of Sall4 on the proliferation, invasion and apoptosis of breast cancer cells. Technol Cancer Res Treat. 19:1533033820980074. doi: 10.1177/1533033820980074
   Web of Science ®Google Scholar
• Lobo J, Acosta AM, Netto GJ. 2023. Molecular biomarkers with potential clinical application in testicular cancer. Mod Pathol. 36:100307.
   PubMed Web of Science ®Google Scholar
• Magers MJ, Idrees MT. 2018. Updates in staging and reporting of testicular cancer. Surg Pathol Clin. 11:813–824.
   PubMedGoogle Scholar
• Miettinen M, Wang Z, McCue PA, Sarlomo-Rikala M, Rys J, Biernat W, Lasota J, Lee YS. 2014. Sall4 expression in germ cell and non-germ cell tumours: a systematic immunohistochemical study of 3215 cases. Am J Surg Pathol. 38(3):410–420. doi: 10.1097/PAS.0000000000000116
   PubMed Web of Science ®Google Scholar
• Sarma RJ, Subbarayan S, Zohmingthanga J, Chenkual S, Zomuana T, Lalruatfela ST, Pautu JL, Maitra A, Kumar NS. 2022. Transcriptome analysis reveals Sall4 as a prognostic key gene in gastric adenocarcinoma. J Egypt Natl Canc Inst. 34(1):11. doi: 10.1186/s43046-022-00108-5
   PubMed Web of Science ®Google Scholar
• Schrader M, Burger AM, Müller M, Krause H, Straub B, Schostak M, Schulze W, Lauke H, Miller K. 2002. The differentiation status of primary gonadal germ cell tumours correlates inversely with telomerase activity and the expression level of the gene encoding the catalytic subunit of telomerase. BMC Cancer. 2(1):32. doi: 10.1186/1471-2407-2-32
   PubMedGoogle Scholar
• Shahin M, Saeednejad Zanjani L, Abolhasani M, Rahbar M, Asgari M, Madjd Z. 2020. Low level expression of human telomerase reverse transcriptase predicts cancer-related death and progression in embryonal carcinoma. J Cancer Res Clin Oncol. 146(11):2753–2775. doi: 10.1007/s00432-020-03319-2
   PubMed Web of Science ®Google Scholar
• Shanmugalingam T, Soultati A, Chowdhury S, Rudman S, Van Hemelrijck M. 2013. Global incidence and outcome of testicular cancer. Clin Epidemiol. 5:417–427.
   PubMedGoogle Scholar
• Siegel RL, Miller KD, Jemal A. 2018. Cancer statistics, 2018. CA Cancer J Clin. 68:7–30.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. 2019. Cancer statistics, 2019. CA Cancer J Clin. 69:7–34.
   PubMed Web of Science ®Google Scholar
• Szymonik J, Wala K, Gornicki T, Saczko J, Pencakowski B, Kulbacka J. 2021. The impact of iron chelators on the biology of cancer stem cells. Int J Mol Sci. 23(1):89.
   PubMed Web of Science ®Google Scholar
• Tatetsu H, Kong NR, Chong G, Amabile G, Tenen DG, Chai L. 2016. Sall4, the missing link between stem cells, development and cancer. Gene. 584(2):111–119. doi: 10.1016/j.gene.2016.02.019
   PubMed Web of Science ®Google Scholar
• Urbini M, Bleve S, Schepisi G, Menna C, Gurioli G, Gianni C, Giorgi UD. 2023. Biomarkers for salvage therapy in testicular germ cell tumours. Int J Mol Sci. 24(23):16872.
   PubMed Web of Science ®Google Scholar
• Wang F, Liu A, Peng Y, Rakheja D, Wei L, Xue D, Allan RW, Molberg KH, Li J, Cao D. 2009. Diagnostic utility of Sall4 in extragonadal yolk sac tumours: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3. Am J Surg Pathol. 33(10):1529–1539. doi: 10.1097/PAS.0b013e3181ad25d5
   PubMed Web of Science ®Google Scholar
• Wang B, Xie Y, Zheng L, Zheng X, Gao J, Liu X, Yuan Y, Li Z, Lu N, Xue L. 2021. Both the serum AFP test and AFP/GPC3/SALL4 immunohistochemistry are beneficial for predicting the prognosis of gastric adenocarcinoma. BMC Gastroenterol. 21(1):408. doi: 10.1186/s12876-021-01986-0
   PubMed Web of Science ®Google Scholar
• Wu P, Luo R, Sun B, Zhao J, Xu Q, Feng S, Chen X, Wang C. 2020. Sall4 is a useful marker for pediatric yolk sac tumours. Pediatr Surg Int. 36(6):727–734. doi: 10.1007/s00383-020-04652-w
   PubMed Web of Science ®Google Scholar
• Yang Y, Wang X, Liu Y, Hu Y, Li Z, Li Z, Bu Z, Wu X, Zhang L, Ji J. 2021. Up-regulation of Sall4 is associated with survival and progression via putative WNT pathway in gastric cancer. Front Cell Dev Biol. 9:600344. doi: 10.3389/fcell.2021.600344
   PubMed Web of Science ®Google Scholar
• Yue X, Xiao L, Yang Y, Liu W, Zhang K, Shi G, Zhou H, Geng J, Ning X, Wu J, et al. 2015. High cytoplasmic expression of Sall4 Predicts a malignant phenotype and poor prognosis of breast invasive ductal carcinoma. Neo. 62(06):980–988. doi: 10.4149/neo_2015_119
   Google Scholar
• Zhu F, Liu Z, Zhou Q, Fan J, Zhou D, Xing L, Bo H, Tang L, Fan L. 2021. Identification of MRNA prognostic markers for TGCT by integration of co-expression and Cerna network. Front Endocrinol (Lausanne). 12:743155. doi: 10.3389/fendo.2021.743155
   PubMed Web of Science ®Google Scholar